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Parkinson’s disease (PD) is a common, adult-onset, neuro-degenerative disorder characterized by the degeneration of
cardinal motor signs mainly due to the loss of dopaminergic neurons in the substantia nigra. To date, researchers still
have limited understanding of the key molecular events that provoke neurodegeneration in this disease. Here, we present
ParkDB, the first queryable database dedicated to gene expression in PD. ParkDB contains a complete set of re-analyzed,
curated and annotated microarray datasets. This resource enables scientists to identify and compare expression signatures
involved in PD and dopaminergic neuron differentiation under different biological conditions and across species.
Database URL: http://www2.cancer.ucl.ac.uk/Parkinson_Db2/
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Introduction
Parkinson’s disease (PD) is both sporadic and genetic
(5–10%) (1). Although several mutated loci have been
identified, they appear to be directly responsible in only a
relatively small number of families. Evidence is accumulat-
ing, however, that the molecular pathways underlying
these genomic regions may be common to more than one
genetic form of Parkinsonism and may also play a role in
the common sporadic disease (2, 3). Causes of sporadic PD
are unknown but a prevalent hypothesis is that it may
result from a complex interaction between toxic environ-
mental factors, genetic susceptibility and aging (4).
Despite the fact that several gene expression studies
focused on PD have been performed (5–14), no database
has been developed to allow full-scale meta-analysis of
microarray data related to PD.
Here, we present ParkDB, a resource that aims to provide
comprehensive access to high quality gene expression data-
sets analyzed in a homogeneous manner. ParkDB has three
main functions:
(i) To collect all microarray data from publicly available
sources such as ArrayExpress (15), Gene Expression
Omnibus (GEO) (16) and the Stanford microarray
database (17), pertaining to PD and to dopaminergic
neuron differentiation.
(ii) To provide access to key differentially expressed
genes across different experiments contained in the
database (i.e. different tissues, cell lines, treatments
and species).
(iii) To provide homogeneous results from the statistical
analysis of microarray data allowing for effective
comparisons between experiments.
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Database schema and content
Data model
ParkDB is a relational database. The entity relationships
between these tables are depicted in Figure 1. The concep-
tual scheme described was designed to facilitate the inclu-
sion of new experiments and associated gene annotations
in future updates.
ParkDB includes microarray data from human diseased
brain areas and other tissues, as well as mouse, rat and
zebrafish samples pertaining to PD affected tissues, PD
animal models and PD-related experiments (Figure 2).
Moreover, it also contains further annotation data asso-
ciated to the genes identified and their orthologues.
In total, more than 800 Affymetrix chips were re-analyzed.
Data insertion process
We download manually the raw data from GEO,
ArrayExpress and Stanford databases every 2 months and
re-analyze/re-annotate them using an automatic script
written in R, which already contains annotation for all
the Affymetrix platforms. Since ParkDB is built directly
from raw data it is not affected by changing formats
or data models of the databases we obtain the data
from. Furthermore, researchers are invited to contact us
to directly upload their data into ParkDB.
Queries
The ParkDB database allows the user to mine the data in
the following ways:
(i) The ‘gene query’ can be performed by typing the
NCBI gene name, the gene symbol, the Affymetrix
probe identifier or the chromosome on which the
gene is located. The resulting output view provides
details on organism name, Affymetrix probe id, the
description of each experiment where the gene was
found to be differentially expressed at chosen
cut-off, and the differential expression values
Figure 1. Entity relationship diagram of ParkDB. The scheme illustrates the tables created for data storage with the respective
attributes and relations. The simple relations between the tables facilitate the possible expansion of the database to other genes
involved in PD neurodegeneration and dopaminergic differentiation.
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(i.e. log2 fold-change, t-test value, adjusted P-value,
Bayesian value for t) (Figure 3).
(ii) The ‘experiment query’ allows searching for a specific
experiment by names/keywords. In this case, a brief
description table will be visualized alongside a list of
all the genes, which were found to be differentially
expressed (Supplementary Figure S1).
(iii) The ‘tissue query’ allows the researcher to search for
specific tissue/cell types that may have been used in
more than one experiment and retrieve the differen-
tially expressed genes relating to those specific
contrasts (Supplementary Figure S2).
(iv) The ‘comparison query’ provides a unique data-
mining feature that has been made possible
because of the homogeneous analysis of the expres-
sion data available in ParkDB. Since we have incorpo-
rated information on orthology, the researcher can
query the database for common genes between two
experiments and across different organisms. The
resulting view will also highlight whether the genes
were found to be up-regulated, down-regulated or
anti-correlated, in two different comparisons
(Figure 4).
Usage example
One of the most useful functions of ParkDB is the possibility
to retrieve expression values for a particular gene in differ-
ent experiments. For example, by querying ParkDB for gene
symbols, we found that a-synuclein (SNCA) is differentially
expressed and down-regulated in the entire set of human
experiments comparing substantia nigra from Parkinson’s
patients against normal controls. SNCA is expected to be
up-regulated in PD patients because it codes for a protein
that forms Lewy bodies, which are the hallmark of PD.
This apparently inconsistent result can be explained by
the fact that total mRNA was extracted from the remain-
ing, more resistant neurons in post-mortem PD samples.
Furthermore, Seo et al. (18) suggested a protective property
for alpha-synuclein at low levels. They found that at nano-
molar concentration alpha-synuclein protects rat cortical
Figure 2. Pie charts and bar plot representing the curated information for each biological tissue, organism and comparison.
Fifty-six percent of resources are retrieved from human experiments, 35% from mouse, 6% from rat and the remaining 3% from
zebrafish. (A). Thirty-three percent of the tissues included in ParkDB were obtained from substantia nigra, 31% from basal
ganglia, 19% from the whole brain, 6% from different regions of cortex and 11% from different tissues such as Blood,
B Lymphocytes, etc. (B).
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Figure 3. Gene query. The table shows the differential expressed genes obtained searching for SNCA. Red and green arrows
indicate, respectively, up- and down-regulation.
Figure 4. Comparison query. The table shows the common genes obtained comparing substantia nigra from PD patients and a
transgenic mice that over-expresses HSP70/SNCA. The resulting view also highlights whether the genes were found to be
up-regulated/down-regulated or anti-correlated, in two different comparisons.
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and hippocampal neuronal cells against serum deprivation
and oxidative stress. This process is mediated by the Akt2
signaling pathway and its protective effect is increased by
Bcl-2 overexpression. This study seems to confirm our
results that show an up-regulation of BCL-2/AKT2 in
human experiments comparing substantia nigra from
Parkinson’s patients against normal samples (Table 1) lead-
ing to the hypothesis that the anti-apoptotic effect of this
pathway in the remaining cells of substantia nigra samples
might represent a system that protects dopaminergic
neurons from cell death. Moreover, higher BCL-2 levels in
Alzheimer’s disease are thought to be related to a compen-
satory up-regulation in response to the neurodegenerative
process (19). Our findings might indicate that the expres-
sion profiling of post-mortem tissue from PD patients
represents a specific signature of surviving neurons. The
down-regulation of SNCA and other genes, however,
might also be related to a significant limitation of
post-mortem tissue, and/or reflect neuron loss and replace-
ment by glia cells.
Data sources
We downloaded raw gene expression data from publicly
available sources such as ArrayExpress, GEO and Stanford
database. ArrayExpress is a repository of microarray data
where files are both uploaded directly by researchers and
imported from GEO. It is regularly queried for experiments
based on keywords pertaining to PD and/or dopaminergic
neuron differentiation. All the experiments which we
import from ArrayExpress have passed their basic quality
control (i.e. the raw data has to be available and no data
files should be corrupted). In a few selected cases,
we import directly data that is missing from Arrayexpress
because it was uploaded on a project/publication specific
website or obtained directly from the scientists involved.
In that case, we perform this basic QC ourselves.
Using biomaRt (20) we were able to retrieve ortholog
gene information from the Ensembl database (21) enabling
users to perform inter-species queries. In order to allow
among class comparisons (CC), we mapped all the CC
genes using Ensembl Gene identifiers (EGIs). If an EGI was
repeated in a single class comparison, we grouped them by
considering the average, maximum, standard deviation of
fold-change and the minimum adjusted P-value. Moreover,
given two CCs, we provided the list of the genes measured
in both the comparisons and, for each gene we provided
the fold-change and the adjusted P-value. If both CCs were
related to the same organism, we searched for those
Ensembl identifiers that were included in both CCs,
alternatively the ortholog gene identifier was used. Term
annotations were derived from controlled vocabularies
(22, 23).
Statistical methods
Analysis of all the microarray data incorporated in the data-
base was performed using LIMMA (24), a Bioconductor (25)
package for the R statistical programming language (http://
www.r-project.org). The statistics employed by this package
is based on the RMA method that provides quantile nor-
malization, a linear transformation and a Bayesian t-test.
The concept of using a t-statistic with a Bayesian adjusted
denominator after a linear model transformation was first
proposed by Smyth et al. (26). Each experiment was ana-
lyzed separately and no cross-experiment or cross-platform
analyses were performed. This was done in order to avoid
the limitations of source differences and batch effects.
The comparison page allows the user to identify which
genes have shown significant expression change across
different experiments, but those values are derived from
an analysis performed within each experiment separately.
Conclusions
ParkDB is the first database, which has collated, curated
and re-analyzed the microarray data pertaining to samples
from PD and dopaminergic neuron differentiation in a
homogeneous manner.
It provides a unique combination of features that allow
the researcher to perform data analysis and discovery of
relationships between genes involved in PD in several
human brain regions, as well as across multiple model or-
ganisms or cell lines.
Its strength lies in the careful re-analysis of all experi-
ments, which ensures that the statistical basis for defining
genes as differentially expressed is comparable. The goal of
this study is to offer the researcher a central repository to
perform meta-analysis queries.
By using the ‘comparison’ feature a researcher can easily
download lists of genes, which are differentially expressed
across tissues, cell lines, treatments and organisms, along
with comparable and reliable statistical parameters for
each gene in each experiment.
Table 1. Gene expression table. SNCA (down-regulated),
BCL2 (up-regulated) and AKT (up-regulated) are significant
differentially expressed comparing substantia nigra in PD
patients against normal control using ParkDB datasets
Gene name Fold-change Average
expression value
P-value
SNCA 2.06 (down-regulated) 7.26 0.02
BCL2 1.82 (up-regulated) 6.25 0.01
AKT2 1.36 (up-regulated) 5.79 0.01
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ParkDB will be regularly updated allowing the data to be
refined continuously with every new ArrayExpress, GEO
and Stanford microarray database version.
Further directions
Future improvements of ParkDB will allow the inclusion
of next-generation sequencing data to fully exploit the
relationship between microarray gene expression and
deep-sequencing data in PD.
Supplementary Data
Supplementary data are available at Database Online.
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